Fluconazole therapy in transplant recipients receiving FK506.
作者信息
Mañez R, Martin M, Raman D, Silverman D, Jain A, Warty V, Gonzalez-Pinto I, Kusne S, Starzl T E
机构信息
University of Pittsburgh Medical Center, Pennsylvania 15213.
出版信息
Transplantation. 1994 May 27;57(10):1521-3. doi: 10.1097/00007890-199405270-00022.
Abstract
摘要
相似文献
1
Fluconazole therapy in transplant recipients receiving FK506.接受FK506治疗的移植受者的氟康唑治疗
Transplantation. 1994 May 27;57(10):1521-3. doi: 10.1097/00007890-199405270-00022.
2
Tacrolimus dosage requirements after initiation of azole antifungal therapy in pediatric thoracic organ transplantation.
Pediatr Transplant. 2003 Dec;7(6):474-8. doi: 10.1046/j.1397-3142.2003.00103.x.
3
Tacrolimus (FK506) malabsorption: management with fluconazole coadministration.他克莫司（FK506）吸收不良：与氟康唑联合给药的管理。
Transpl Int. 1997;10(4):331-4. doi: 10.1007/s001470050066.
4
Clinically significant drug-drug interaction between tacrolimus and fluconazole in stable renal transplant recipient and literature review.他克莫司与氟康唑在稳定期肾移植受者中具有临床显著意义的药物相互作用及文献复习。
J Clin Pharm Ther. 2020 Apr;45(2):264-269. doi: 10.1111/jcpt.13075. Epub 2019 Nov 22.
5
Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.静脉注射大剂量氟康唑与环孢素或他克莫司在骨髓移植患者中的药物相互作用评估。
Transplantation. 1996 Apr 27;61(8):1268-72. doi: 10.1097/00007890-199604270-00026.
6
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.氟康唑与小剂量两性霉素B预防骨髓移植患者真菌感染的比较：北美骨髓移植组的一项研究
Bone Marrow Transplant. 2000 Apr;25(8):853-9. doi: 10.1038/sj.bmt.1702233.
7
Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation.胰腺/肾脏移植中他克莫司使用的建议指南。
Clin Transplant. 1998 Jun;12(3):260-2.
8
Antifungal agents for preventing fungal infections in solid organ transplant recipients.用于预防实体器官移植受者真菌感染的抗真菌药物。
Cochrane Database Syst Rev. 2004(3):CD004291. doi: 10.1002/14651858.CD004291.pub2.
9
Concomitant letermovir affects the optimal concentration-to-dose ratio of tacrolimus after switching from intravenous to oral tacrolimus administration in hematopoietic cell transplantation patients receiving fluconazole prophylaxis.在接受氟康唑预防治疗的造血细胞移植患者中，同时使用来特莫韦会影响从静脉注射他克莫司转换为口服他克莫司给药后他克莫司的最佳浓度-剂量比。
Int J Hematol. 2025 Apr;121(4):462-466. doi: 10.1007/s12185-025-03942-0. Epub 2025 Feb 10.
10
Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients.CYP3A5和MDR1单核苷酸多态性对肾移植受者中他克莫司与氟康唑药物相互作用的影响。
Pharmacogenet Genomics. 2008 Oct;18(10):861-8. doi: 10.1097/FPC.0b013e328307c26e.
引用本文的文献
1
Drug Interactions and Safe Prescription Writing for Liver Transplant Recipients.肝移植受者的药物相互作用与安全处方书写
J Clin Exp Hepatol. 2023 Sep-Oct;13(5):869-877. doi: 10.1016/j.jceh.2023.03.011. Epub 2023 Apr 1.
2
Recommendations on the use of azole antifungals in hematology-oncology patients.血液病-肿瘤患者中唑类抗真菌药物的应用建议。
Rev Esp Quimioter. 2023 Jun;36(3):236-258. doi: 10.37201/req/013.2023. Epub 2023 Apr 5.
3
Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients.群体药代动力学模型的适应性调整以指导心脏移植受者的他克莫司治疗。
Br J Clin Pharmacol. 2023 Mar;89(3):1162-1175. doi: 10.1111/bcp.15566. Epub 2022 Nov 6.
4
Insight into the Inclusion Complexation of Fluconazole with Sulfonatocalix[4]naphthalene in Aqueous Solution, Solid-State, and Its Antimycotic Activity.氟康唑与磺化杯[4]萘在水溶液、固态中的包结作用及其抗真菌活性的深入研究。
Molecules. 2022 Jul 11;27(14):4425. doi: 10.3390/molecules27144425.
5
Endemic Mycoses in Solid Organ Transplant Recipients.实体器官移植受者的地方性真菌病。
Infect Dis Clin North Am. 2018 Sep;32(3):667-685. doi: 10.1016/j.idc.2018.04.007.
6
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.抗真菌药物的药代动力学：优化患者治疗的实际意义。
Infection. 2017 Dec;45(6):737-779. doi: 10.1007/s15010-017-1042-z. Epub 2017 Jul 12.
7
Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults.药物相互作用的药代动力学评估：伊曲康唑与环孢素、霉酚酸、泼尼松龙、西罗莫司和他克莫司在健康成年人中的相互作用。
Clin Pharmacol Drug Dev. 2017 Jan;6(1):76-85. doi: 10.1002/cpdd.284. Epub 2016 Jul 25.
8
[Strategies for antifungal treatment failure in intensive care units].[重症监护病房抗真菌治疗失败的策略]
Anaesthesist. 2015 Sep;64(9):643-58. doi: 10.1007/s00101-015-0072-0.
9
Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective.三唑类药物的治疗药物监测：从加拿大角度进行的需求评估综述和建议。
Can J Infect Dis Med Microbiol. 2014 Nov-Dec;25(6):327-43. doi: 10.1155/2014/340586.
10
本文引用的文献
1
Fungal Infections After Liver Transplantation.肝移植后的真菌感染
Transplant Proc. 1988 Feb 1;20(1):650-651.
2
Fungal infections in liver transplant recipients.肝移植受者中的真菌感染
Transplantation. 1985 Oct;40(4):347-53. doi: 10.1097/00007890-198510000-00002.
3
Interaction between cyclosporine and fluconazole in renal allograft recipients.肾移植受者中环孢素与氟康唑的相互作用。
Transplantation. 1991 May;51(5):1014-8. doi: 10.1097/00007890-199105000-00016.
4
Clinical spectrum of fungal infections after orthotopic liver transplantation.原位肝移植后真菌感染的临床谱
Arch Surg. 1991 Feb;126(2):149-56. doi: 10.1001/archsurg.1991.01410260033005.
5
Fluconazole in the treatment of hepatosplenic candidiasis.氟康唑治疗肝脾念珠菌病。
Arch Intern Med. 1992 Feb;152(2):406-8.
6
FK 506 in clinical kidney transplantation.FK506在临床肾移植中的应用
Transplant Proc. 1991 Dec;23(6):3065-7.
7
The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation.FK 506作为成人心脏移植主要及挽救性免疫抑制治疗的临床试验。
Transplant Proc. 1991 Dec;23(6):3054-7.
8
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.一项关于在免疫抑制下使用FK 506与环孢素进行原位肝移植的随机试验。
Transplant Proc. 1991 Dec;23(6):2977-83.
9
Pharmacokinetics of FK 506 in transplant patients.FK506在移植患者中的药代动力学。
Transplant Proc. 1991 Dec;23(6):2736-40.
10
Practical aspects of FK 506 analysis (Pittsburgh experience).FK506分析的实践方面（匹兹堡经验）。
Transplant Proc. 1991 Dec;23(6):2730-1.
Zotero 插件